RU85493

RU85493 is an experimental small molecule compound classified as a dipeptide derivative. Its chemical structure includes an azepan ring and a biphenyl group. RU85493 has been identified as an inhibitor of the proto-oncogene tyrosine-protein kinase Src (commonly known as Src kinase), which is involved in various cellular signaling pathways related to cell growth and differentiation. The drug’s primary mechanism of action is believed to be inhibition of Src kinase activity in human cells[1][4]. There are no approved indications or marketed uses for this compound; it remains at the experimental stage.

Other names

2-(4-((2S)-2-(((3S)-1-(((1,1'-biphenyl)-4-yl)methyl)-2-oxoazepan-3-yl)carbamoyl)-2-acetamidoethyl)-2-phosphonophenoxy)acetic acid2-{4-[(2S)-2-{[(3S)-1-({[1,1'-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]carbamoyl}-2-acetamidoethyl]-2-phosphonophenoxy}acetic acid{4-[2-acetylamino-2-(1-biphenyl-4-ylmethyl–2–oxo–azepan–3–ylcarbamoyl)–ethyl]–2-phosphono–phenoxy}acetic acid